Mar 01, 2018
Achieve Announces Recent Highlights and Reports Year-End 2017 Financial Results
Feb 20, 2018
Achieve Announces Preliminary Data from Cytisine Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study
Feb 15, 2018
The global industrial alcohol market is expected to reach USD 223.63 billion by 2025
Dec 05, 2017
Study Shows Lithium Chloride Blunts Brain Damage Linked to Fetal Alcohol Syndrome
Nov 29, 2017
Lenalidomide Market to Grow on Account of Rising Usage in Treatment of Anemia & Multiple Myeloma Diseases till 2021: Million Insights
Nov 28, 2017
Achieve Announces Clinical Trial Supply and Cooperation Agreement with the University of Auckland for the Evaluation of Cytisine Compared to Varenicline for Smoking Cessation
Nov 14, 2017
Monopar Therapeutics, Inc. Announces Acquisition of GPX-150, a Broad Spectrum Phase II Cancer Drug Candidate, Closing on $9.7M in Financing, and Filing of Form 10 Registration Statement
Nov 14, 2017
Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability of Cytisine in Fed and Fasted Subjects
Nov 09, 2017
Achieve Reports Financial Results for Third Quarter 2017
Nov 08, 2017
Achieve to Present at the 29th Annual Piper Jaffray Healthcare Conference on November 28th, 2017
Nov 06, 2017
Achieve Announces Availability of Company Presentation from the Virtual Investor Conference
Oct 30, 2017
Achieve Announces Company Presentation at Virtual Investor Conference on November 2, 2017
Oct 30, 2017
Lannett And Celgene Enter Into Settlement And License Agreement Related To Thalomid®
Oct 26, 2017
Achieve Announces Exclusive, Long-term Manufacturing Agreement with Sopharma for Clinical and Commercial Supply of Cytisine
Oct 18, 2017
Final Data on Phase I/II in Small-cell Lung Cancer with Zepsyre® Presented at the IASCLC 18th World Conference on Lung Cancer in Japan
Oct 10, 2017
PharmaMar Will Present Final Data on PM1183 During the 18th World Lung Conference in Japan
Oct 04, 2017
Achieve Announces Advancement of Cytisine Clinical Development Program
Aug 16, 2017
Achieve Announces Initiation of Cytisine Clinical Development Program
Aug 10, 2017
Achieve Announces FDA Acceptance of the Investigational New Drug Application (IND) for Cytisine as a Smoking Cessation Treatment
Aug 01, 2017
Achieve Life Sciences Announces Closing of Merger with OncoGenex Pharmaceuticals